Table 1.
Demographic data of IBD contacts to the CCS.
| Overall population | Pre-COVID 19 (January–February 2020) |
During COVID-19 (March–April 2020) |
|
|---|---|---|---|
| IBD patients contacted CCS number (n) | 1852 | 881 | 971 |
| Disease n (%): | |||
| CD | 1056 (57%) | 489 (55.5%) | 567 (58.4%) |
| UC | 741 (40%) | 354 (40.2%) | 387 (39.8%) |
| IBD-unclassified | 55 (3%) | 38 (4.3%) | 17 (1.8%) |
| Sex n (%): | |||
| M | 1037 (56%) | 494 (56.1%) | 543 (55.9%) |
| F | 815 (44%) | 387 (43.9%) | 428 (44.1%) |
| Age n (%): | |||
| 14–20 yr. | 315 (17%) | 154 (17.5%) | 161 (16.6%) |
| 21–30 yr. | 407 (22%) | 184 (20.9%) | 223 (23%) |
| 31–40 yr. | 241 (13%) | 115 (13%) | 126 (13%) |
| 41–50 yr. | 333 (18%) | 151 (17.2%) | 182 (18.7%) |
| 51–60 yr. | 315 (17%) | 159 (18.1%) | 156 (16.1%) |
| > 60 yr. | 241 (13%) | 118 (13.3%) | 123 (12.7%) |
CCS, contact centre service; CD, Crohn's disease; COVID-19, coronavirus disease 2019; IBD, inflammatory bowel disease; UC, ulcerative colitis; yr, years.